Eficacia y seguridad de pembrolizumab más lenvatinib más quimioterapia en participantes con carcinoma esofágico metastásico
The purpose of this study is to assess the efficacy and safety of pembrolizumab plus lenvatinib plus chemotherapy compared with pembrolizumab plus chemotherapy as first-line intervention in participants with metastatic esophageal